QuidelOrtho Launches High-Sensitivity Troponin for 0/1-Hour Cardiac Rule-Out Protocols
QuidelOrtho’s latest Science Bytes podcast details how its high-sensitivity troponin assay accelerates cardiac injury detection with 0/1- and 0/2-hour testing protocols, cutting emergency department time. The assay’s tight reproducibility at low troponin levels and sex-specific cutoffs enhance diagnostic precision and equitable care across patient groups.
1. Podcast Episode Highlights
QuidelOrtho released Episode 56 of its Science Bytes podcast featuring Dr. Lindy Carlstrom, Global Medical Affairs Manager for Acute Care. The discussion centers on high-sensitivity troponin’s role in transforming early cardiac diagnosis and supporting faster clinical decisions.
2. Diagnostic Performance Improvements
The high-sensitivity troponin assay offers tight reproducibility at low troponin levels, enabling clinicians to distinguish true myocardial injury from analytical noise. This precision supports more confident rule-in and rule-out decisions in suspected cardiac events.
3. Clinical Pathway Impact
Shortened serial testing intervals using 0/1- and 0/2-hour protocols allow rapid rule-out of heart attacks, reducing emergency department length of stay and speeding patient flow. Faster detection of cardiac injury improves resource utilization and emergency throughput.
4. Future Research Directions
Emerging research explores applications in cardio-oncology, perioperative care, and long-term cardiovascular risk prediction. The incorporation of sex-specific cutoffs aims to ensure consistent diagnostic accuracy across diverse patient populations.